Previous 10 | Next 10 |
PRINCETON, N.J., April 27, 2022 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, today reported financial results for the first quarter ending March 31, 2022. First Quarter 2022 Highlights Revenues...
Integra LifeSciences Holdings (NASDAQ:IART) is scheduled to announce Q1 earnings results on Wednesday, April 27th, before market open. The consensus EPS Estimate is $0.68 (-1.4% Y/Y) and the consensus Revenue Estimate is $362.19M (+0.6% Y/Y). Over the last 2 years, IART has beaten EPS estimat...
PRINCETON, N.J., April 01, 2022 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will release first quarter 2022 financial results on Wednesday, April 27, 2022, prior to the market open. In conjunction wi...
PRINCETON, N.J., March 22, 2022 (GLOBE NEWSWIRE) -- Integra LifeSciences Holding Corporation (Nasdaq: IART), a leading global medical technology company and pioneers in nerve repair, today announced the launch of NeuraGen ® 3D Nerve Guide Matrix , a resorbable implant f...
Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...
Integra LifeSciences Holdings Corporation (IART) Q4 2021 Earnings Conference Call February 23, 2022 08:30 AM ET Company Participants Chris Ward - Senior Director of Investor Relations Jan De Witte - President & Chief Executive Officer Glenn Coleman - Chief Operating Officer Carrie Anderso...
The following slide deck was published by Integra LifeSciences Holdings Corporation in conjunction with their 2021 Q4 earnings call. For further details see: Integra LifeSciences Holdings Corporation 2021 Q4 - Results - Earnings Call Presentation
Integra LifeSciences Holdings press release (NASDAQ:IART): Q4 Non-GAAP EPS of $0.84 in-line. Revenue of $405.5M (+4.3% Y/Y) beats by $2.09M. For the first quarter 2022, the Company expects reported revenues in the range of $357 million to $365 million vs. consensus of $378.84M, representing r...
PRINCETON, N.J., Feb. 23, 2022 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART) today reported financial results for the fourth quarter and full year ended December 31, 2021, consistent with its preliminary revenue results announced on January 11, 2022. ...
Integra LifeSciences Holdings (NASDAQ:IART) is scheduled to announce Q4 earnings results on Wednesday, February 23rd, before market open. The consensus EPS Estimate is $0.84 (flat Y/Y) and the consensus Revenue Estimate is $403.41M (+3.8% Y/Y). Over the last 2 years, IART has beaten EPS estim...
News, Short Squeeze, Breakout and More Instantly...
Trending Stock
21.25%Change Percent:
Integra LifeSciences Holdings Corporation Company Name:
IART Stock Symbol:
NASDAQ Market:
Integra LifeSciences Holdings Corporation Website:
2024-07-30 06:00:06 ET Joanne Wuensch from Citigroup issued a price target of $23.00 for IART on 2024-07-30 03:24:00. The adjusted price target was set to $23.00. At the time of the announcement, IART was trading at $25.42. The overall price target consensus is at $47.00...
2024-07-29 18:00:04 ET Ryan Zimmerman from BTIG issued a price target of $22.00 for IART on 2024-07-29 16:12:00. The adjusted price target was set to $22.00. At the time of the announcement, IART was trading at $25.42. The overall price target consensus is at $51.17 with...
2024-07-29 17:15:01 ET BTIG analyst issues SELL recommendation for IART on July 29, 2024 04:12PM ET. IART was trading at $25.42 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analyst recommendations are : 2 - Buy, 2 - Hold, 1 - Sell ...